US Patent Issued to American Gene Technologies International on Feb. 24 for "Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells" (Maryland Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,769, issued on Feb. 24, was assigned to American Gene Technologies International Inc. (Rockville, Md.).

"Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells" was invented by Charles David Pauza (Rockville, Md.), Tyler Lahusen (Rockville, Md.), Haishan Li (Rockville, Md.), Mei-Ling Liou (Rockville, Md.) and Lingzhi Xiao (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to methods and compositions for activating gamma-delta (GD) T cells. Such methods and compositions can be used to treat cancer."

The patent was filed on June 15, 2018, under Application N...